REFERENCES
- Doelling M. K., Jones D. M., Smith R. A., Nash R. A. Pharm. Res. 1992; 9: 1487
- Doelling M. K., Nash R. A. Pharm. Res. 1992; 9: 1493
- Waldron M. S. Pharm. Eng. 1988; 8: 9
- Duschler G., Carius W., Bauer K. H. Drug. Dev. Ind. Pharm. 1995; 21: 1599
- Vromans H. Eur. J. Pharm. Biopharm. 1994; 40: 333
- Mandal T. K. Drug. Dev. Ind. Pharm. 1995; 21: 1683
- Franz R. M., Browne J. E., Lewis A. R. Experimental design, modeling, and optimization strategies for product and process development. Pharmaceutical Dosage Forms. Disperse Systems, H. A. Lieberman, M. M. Rieger, G. S. Banker. Marcel Dekker, New York 1988; 1: 427–455
- Selkirk A. B., Ganderton D. J. Pharm. Pharmacol. Suppl. 1970; 22: 79S
- Ganderton D., Selkirk A. B. J. Pharm. Pharmacol. Suppl. 1970; 22: 86S
- Wikberg M., Alderborn G. Granule properties. Pharmaceutical Powder Compaction Technology, M. Wikberg, G. Alderborn. Marcel Dekker, New York 1996; 323–373